stoxline Quote Chart Rank Option Currency Glossary
Comera Life Sciences Holdings, Inc. (CMRA)
0.0627  -0.002 (-3.54%)    11-29 10:52
Open: 0.0667
High: 0.0667
Volume: 7,560
Pre. Close: 0.065
Low: 0.0627
Market Cap: 2(M)
Technical analysis
2023-11-29 10:46:03 AM
Short term     
Mid term     
Targets 6-month :  0.28 1-year :  0.43
Resists First :  0.24 Second :  0.37
Pivot price 0.15
Supports First :  0.02 Second :  0.02
MAs MA(5) :  0.06 MA(20) :  0.19
MA(100) :  0.4 MA(250) :  0.75
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  10.7 D(3) :  9.7
RSI RSI(14): 28.8
52-week High :  2.17 Low :  0.02
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CMRA ] has closed above bottom band by 29.3%. Bollinger Bands are 140.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.07 - 0.07 0.07 - 0.07
Low: 0.06 - 0.06 0.06 - 0.06
Close: 0.06 - 0.07 0.07 - 0.07
Company Description

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Headline News

Tue, 21 Nov 2023
Comera Life Sciences Holdings, Inc.(OTCPK : CMRA) dropped from ... -

Mon, 13 Nov 2023
Comera Life Sciences Designates Dorothy Clarke to Board of ... - Yahoo Finance

Thu, 09 Nov 2023
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights - Yahoo Finance

Thu, 21 Sep 2023
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday’s Mid-D - Benzinga

Tue, 12 Sep 2023
Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session - Aurora - Benzinga

Sat, 26 Aug 2023
These Are the ONLY 7 Penny Stocks to Consider in August 2023 - InvestorPlace

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out -3 (M)
Shares Float 0 (M)
Held by Insiders 3.074e+007 (%)
Held by Institutions 1.218e+007 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 422710
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.22
Profit Margin 0 %
Operating Margin -1 %
Return on Assets (ttm) 582.4 %
Return on Equity (ttm) -119.4 %
Qtrly Rev. Growth 629 %
Gross Profit (p.s.) 95.58
Sales Per Share 187.12
EBITDA (p.s.) 352258
Qtrly Earnings Growth -7.55e+006 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value -0.31
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 281550
Forward Dividend 27930
Dividend Yield 422114000%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android